371 related articles for article (PubMed ID: 31239092)
1. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
Heendeniya A; Bogoch II
Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
Kalapila AG; Marrazzo J
Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622
[TBL] [Abstract][Full Text] [Related]
3. Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
Huang YA; Tao G; Samandari T; Hoover KW
J Infect Dis; 2018 Jan; 217(4):617-621. PubMed ID: 29145597
[TBL] [Abstract][Full Text] [Related]
4. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
5. Prevention Strategies Against HIV Transmission: A Proactive Approach.
Carrion AJ; Miles JD; Mosley JF; Smith LL; Prather AS; Gurley MM; Phan LD; Everton EC
J Pharm Pract; 2018 Feb; 31(1):82-90. PubMed ID: 29278971
[TBL] [Abstract][Full Text] [Related]
6. Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion.
Al-Hajjar SH; Frayha HH; Al-Hazmi M; Batawi R; McIntosh K; Sax PE; Al-Thawadi S; Al-Jumaah S; Busch MP; Hanhauser E; Kuritzkes DR; Li JZ; Henrich TJ
AIDS; 2014 Jun; 28(10):1539-41. PubMed ID: 24896805
[No Abstract] [Full Text] [Related]
7. ARV-based HIV prevention for women - where we are in 2014.
Mastro TD; Sista N; Abdool-Karim Q
J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614
[TBL] [Abstract][Full Text] [Related]
8. HIV Pre-Exposure Prophylaxis and Postexposure Prophylaxis in Japan: Context of Use and Directions for Future Research and Action.
DiStefano AS; Takeda M
AIDS Patient Care STDS; 2017 Feb; 31(2):60-77. PubMed ID: 28170304
[TBL] [Abstract][Full Text] [Related]
9. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N
Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147
[TBL] [Abstract][Full Text] [Related]
10. Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception.
Delany-Moretlwe S; Mullick S; Eakle R; Rees H
Curr Opin HIV AIDS; 2016 Jan; 11(1):87-93. PubMed ID: 26575146
[TBL] [Abstract][Full Text] [Related]
11. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis.
Krakower DS; Jain S; Mayer KH
Curr HIV/AIDS Rep; 2015 Mar; 12(1):127-38. PubMed ID: 25600106
[TBL] [Abstract][Full Text] [Related]
12. What does preexposure prophylaxis mean for treatment; what does treatment mean for preexposure prophylaxis?
Venter WD
Curr Opin HIV AIDS; 2016 Jan; 11(1):35-40. PubMed ID: 26545265
[TBL] [Abstract][Full Text] [Related]
13. The European preexposure prophylaxis revolution.
Cairns G; McCormack S; Molina JM
Curr Opin HIV AIDS; 2016 Jan; 11(1):74-9. PubMed ID: 26599164
[TBL] [Abstract][Full Text] [Related]
14. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
Cowan FM; Delany-Moretlwe S
Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
[TBL] [Abstract][Full Text] [Related]
15. Postexposure prophylaxis for HIV following sexual exposure.
Barber TJ; Benn PD
Curr Opin HIV AIDS; 2010 Jul; 5(4):322-6. PubMed ID: 20543608
[TBL] [Abstract][Full Text] [Related]
16. Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation.
Landovitz RJ
Top Antivir Med; 2015; 23(2):85-90. PubMed ID: 26200708
[TBL] [Abstract][Full Text] [Related]
17. Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.
Blashill AJ; Ehlinger PP; Mayer KH; Safren SA
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S187-90. PubMed ID: 25972502
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.
Kessler J; Myers JE; Nucifora KA; Mensah N; Toohey C; Khademi A; Cutler B; Braithwaite S
AIDS; 2014 Nov; 28(18):2683-91. PubMed ID: 25493594
[TBL] [Abstract][Full Text] [Related]
19. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
Haberer JE
Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.
Tumarkin E; Heendeniya A; Murphy P; Placido T; Tan DHS; Bogoch II
J Acquir Immune Defic Syndr; 2018 May; 78(1):20-22. PubMed ID: 29419570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
